The TBK1/IKKε inhibitor amlexanox improves dyslipidemia and prevents atherosclerosis

Peng Zhao, Xiaoli Sun, Zhongji Liao, Hong Yu, Dan Li, Zeyang Shen, Christopher K. Glass, Joseph L. Witztum, Alan R. Saltiel

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'The TBK1/IKKε inhibitor amlexanox improves dyslipidemia and prevents atherosclerosis'. Together they form a unique fingerprint.

Medicine and Dentistry

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science